Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03784612
Other study ID # Dnr: 2018/652-31
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 15, 2019
Est. completion date August 31, 2023

Study information

Verified date October 2023
Source Karolinska Institutet
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to investigate the effect of using new app-based technology to improve dietary habits, compared to usual care in patients with type 2 diabetes. The hypothesis is that the intervention, i.e. using the new technology an an app-based course for healthy eating habits, will have a greater positive effect on dietary habits and biological markers, including HbA1c and serum lipids, than usual care.


Recruitment information / eligibility

Status Completed
Enrollment 133
Est. completion date August 31, 2023
Est. primary completion date August 31, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Have a diagnosis of type 2 diabetes - 18 years of age or older - Ability to communicate in Swedish - Own and use a smartphone with a personal digital ID Exclusion criteria: - No specific exclusion criteria apply

Study Design


Intervention

Behavioral:
App-technology for healthy eating habits
Access to smartphone-app, including a 12 week healthy eating program. A new theme on healthy dietary habits is presented each week.

Locations

Country Name City State
Sweden Karolinska Institutet Stockholm

Sponsors (1)

Lead Sponsor Collaborator
Karolinska Institutet

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Other Change in dietary intake and eating habits Assessed using a 94 item food frequency questionnaire (FFQ) Baseline and month 3, 6 and 12
Other Change in eating behaviour assessed using Three-Factor Eating Questionnaire-R21 (TFEQ-R21) Assessed using a 21-item questionnaire Baseline and month 3, 6 and 12
Other Change in physical activity assessed using the Active-Q questionnaire Assessed using a 48 item questionnaire including activities in domains of Daily occupation, transportation, leisure time, and exercise Baseline and month 3, 6 and 12
Other Change in self-reported medication use One question on medication use for blood sugar levels and one questions on medication use for blood lipid levels Baseline and month 3, 6 and 12
Other Change in tobacco use habits Two questions regarding smoking and Swedish snuff use Baseline and month 3, 6 and 12
Other Change in sleeping habits Assessed using a modified 13-item Karolinska Sleep questionnaire Baseline and month 3, 6 and 12
Other Change in perceived purpose in Life (PIL) Assessed using 6-item questionnaire Baseline and month 3, 6 and 12
Other Change in perceived stress levels Assessed using the 14-item perceived stress scale (PSS) Baseline and month 3, 6 and 12
Other Change in self-reported diabetes self-efficacy Assessed using a 20-item questionnaire Baseline and month 3, 6 and 12
Other Change in health related quality of life Assessed using the 36-item RAND-36 questionnaire Baseline and month 3, 6 and 12
Other Change in perceived social support from family and friends for healthy eating habits Assessed using a 3-item questionnaire Baseline and month 3, 6 and 12
Primary Change in dietary intake Change in dietary intake assessed using a four day food record Baseline and month 3, and 6
Secondary HbA1c mmol/mol, Heamoglobin A1c Baseline and month 3, and 6
Secondary Total cholesterol mmol/L Baseline and month 3, and 6
Secondary HDL-cholesterol mmol/L Baseline and month 3, and 6
Secondary Triglycerides mmol/L Baseline and month 3, and 6
Secondary Body Mass Index (BMI) kg/m2, measured height and weight Baseline and month 3, and 6
Secondary Body weight kg, measured Baseline and month 3, and 6
Secondary Body composition: Body fat Body fat (kg), measured using a bioelectrical scale Baseline and month 3, and 6
Secondary Body composition: Fat free mass Fat free mass (kg), measured using a bioelectrical scale Baseline and month 3, and 6
Secondary Body composition: Muscle mass Muscle mass (kg), measured using a bioelectrical scale Baseline and month 3, and 6
Secondary Body composition: Total body water Total body water (kg), measured using a bioelectrical scale Baseline and month 3, and 6
Secondary Waist circumference cm, measured Baseline and month 3, and 6
Secondary Blood pressure mmHg, measured Baseline and month 3, and 6
See also
  Status Clinical Trial Phase
Completed NCT02771093 - An Exploratory Study of the Effects of Trelagliptin and Alogliptin on Glucose Variability in Patients With Type 2 Diabetes Mellitus Phase 4
Completed NCT02545842 - Assessment Study of Three Different Fasting Plasma Glucose Targets in Chinese Patients With Type 2 Diabetes Mellitus (BEYOND III/FPG GOAL) Phase 4
Recruiting NCT03436212 - Real-Life Home Glucose Monitoring Over 14 Days in T2D Patients With Intensified Therapy Using Insulin Pump. N/A
Completed NCT03244800 - A Study to Investigate Different Doses of 0382 in Overweight and Obese Subjects With Type 2 Diabetes Mellitus. Phase 2
Completed NCT03960424 - Diabetes Management Program for Hispanic/Latino N/A
Withdrawn NCT02769091 - A Study in Adult Patients With Nonalcoholic Steatohepatitis Who Also Have Type 2 Diabetes Phase 2
Recruiting NCT06065540 - A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor Phase 3
Recruiting NCT05008276 - Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
Completed NCT04091373 - A Study Investigating the Pharmacokinetics of a Single Dose Administration of Cotadutide Phase 1
Completed NCT03296800 - Study to Evaluate Effects of Probenecid, Rifampin and Verapamil on Bexagliflozin in Healthy Subjects Phase 1
Recruiting NCT06212778 - Relationship Between Nutritional Status, Hand Grip Strength, and Fatigue in Hospitalized Older Adults With Type 2 Diabetes Mellitus.
Completed NCT05979519 - Fresh Carts for Mom's to Improve Food Security and Glucose Management N/A
Recruiting NCT05579314 - XW014 in Healthy Subjects and Patients With Type 2 Diabetes Mellitus (T2DM) Phase 1
Completed NCT03859934 - Metabolic Effects of Melatonin Treatment Phase 1
Terminated NCT03684642 - Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Phase 3
Completed NCT03248401 - Effect of Cilostazol on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes Phase 4
Completed NCT03644134 - A Personalized Intervention to Manage Physiological Stress and Improve Sleep Patterns N/A
Completed NCT05295160 - Fasting-Associated Immune-metabolic Remission of Diabetes N/A
Completed NCT02836873 - Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal Impairment Phase 3
Completed NCT02226003 - Efficacy and Safety of Ertugliflozin (MK-8835/PF-04971729) With Sitagliptin in the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Diet and Exercise (MK-8835-017) Phase 3